Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Market Capitalization	14	20	22	21	9	26
Market Cap Growth	-42.00%	-7.92%	6.81%	121.17%	-64.76%	56.16%
Enterprise Value	20	26	25	23	11	28
Last Close Price	0.10	0.15	0.17	0.17	0.09	0.26
PS Ratio	5.17	7.31	10.56	20.20	12.98	15.10
PB Ratio	-2.00	-2.83	-4.23	-6.53	-3.49	105.16
P/TBV Ratio	-	-	-	-	-	105.16
EV/Sales Ratio	7.08	9.35	11.79	23.00	15.75	15.81
Debt / Equity Ratio	-0.74	-0.74	-0.50	-0.78	-0.79	5.70
Net Debt / Equity Ratio	-0.74	-0.74	-0.50	-0.73	-0.78	5.56
Net Debt / EBITDA Ratio	-3.20	-3.20	-0.65	-0.83	-0.65	-0.37
Net Debt / FCF Ratio	-19.57	-19.57	-2.25	-1.00	-2.43	-0.46
Asset Turnover	1.13	1.13	1.19	0.49	0.27	0.51
Inventory Turnover	6.78	6.78	4.25	2.79	1.67	1.26
Quick Ratio	0.02	0.02	0.05	0.13	0.04	0.09
Current Ratio	0.04	0.04	0.10	0.23	0.09	0.25
Return on Assets (ROA)	-55.19%	-55.19%	-148.14%	-93.37%	-83.34%	-77.93%
Return on Capital Employed (ROCE)	42.10%	42.10%	80.10%	298.70%	134.20%	-698.60%
Earnings Yield	-23.66%	-16.72%	-24.54%	-20.89%	-40.87%	-32.08%
FCF Yield	-1.89%	-1.34%	-5.23%	-11.13%	-9.27%	-11.49%
Buyback Yield / Dilution	-6.73%	-6.73%	-18.68%	-1.50%	-3.19%	-28.83%

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error